A randomised trial of lung sealant<i>versus</i>medical therapy for advanced emphysema
George R. Washko(Brigham and Women's Hospital), Gerard J. Criner(Temple Lung Center), Samaan Rafeq, Grigoris Stratakos, Mordechai R. Kramer(Hadassah Academic College), Michael Boyd, Thomas R. Gildea, Patrick Whitten, Mark T. Dransfield(University of Alabama at Birmingham), Surya P. Bhatt(University of Alabama at Birmingham), John Walsh, Mark H. Gotfried(Pulmonary Associates), Muhanned Abu‐Hijleh, Dirk‐Jan Slebos, Javier Flandes, Javier J. Zulueta, Alexander M. Sy, Alexander C. Chen, Víctor Pinto-Plata(St. Elizabeth's Medical Center), Nathaniel Marchetti, Roger D. Yusen, David Berkowitz, Michela Bezzi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Kumaran Kolandaivelu, Timothy Liesching, Christopher B. Cooper, Larry Tsai, D. Kyle Hogarth(MACOM (United States)), Michael A. Pritchett, Richard A. Mularski, J. Michael Wells(University of Alabama at Birmingham), Enrique Cases, Momen M. Wahidi(Cancer Institute (WIA)), Edmundo Rubio, Charles‐Hugo Marquette(Hôpital Pasteur), William Leeds
Cited by 122
Related Papers
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|560